ECO Animal Health Group Final Earnings Report

ECO Animal Health Group EPS Results

• Actual EPS: GBX 2.49
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

ECO Animal Health Group Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

ECO Animal Health Group Announcement Details

• Quarter: Final
• Date: 7/14/2025
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.